Evidence map›Paper›PMID 41746047›Full record

ArticleVaccines2026

An Evaluation of the Safety and Immunogenicity of a Recombinant Protein-Based Pneumococcal Vaccine in ICR Mice and Cynomolgus Macaque Models.

Xiuwen Sui, Ying Yang, Qingfu Xu, Xiao Xu, Dongxia Zhang, Kang Li, Jiangjiao Li, Qingshan Mo, Junqiang Li, Bo Hao and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xiuwen SuiCanSino Biologics Research Center, Tianjin 300457, China.
Ying YangCanSino Biologics Research Center, Tianjin 300457, China.
Qingfu XuCanSino Biologics Research Center, Tianjin 300457, China.
Xiao XuNHC Key Laboratory of Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China.
Dongxia ZhangJOINN Laboratories (China) Co., Ltd., Beijing 100176, China.
Kang LiNHC Key Laboratory of Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China.
Jiangjiao LiNHC Key Laboratory of Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China.ORCID 0009-0005-5936-038X
Qingshan MoCanSino Biologics Research Center, Tianjin 300457, China.
Junqiang LiCanSino Biologics Research Center, Tianjin 300457, China.
Bo HaoCanSino Biologics Research Center, Tianjin 300457, China.
Weixue SiCanSino Biologics Research Center, Tianjin 300457, China.
Jianming ShiCanSino Biologics Research Center, Tianjin 300457, China.
Zhongqi ShaoCanSino Biologics Research Center, Tianjin 300457, China.
Xuefeng YuCanSino Biologics Research Center, Tianjin 300457, China.
Tao ZhuCanSino Biologics Research Center, Tianjin 300457, China.ORCID 0000-0003-4197-0065

Funding

Development Center for Medical Science & Technology 2014ZX09102046National Health Commission of the people's Republic of China 2018ZX09101001-001-002State Key Laboratory of Drug Regulatory Science 2024SKLDRS0209Tianjin Science and Technology Bureau 25ZGSSSS00010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunogenicitynon-human primaterecombinant pneumococcal proteinsStreptococcus pneumoniae

Identifiers

PMID41746047
PMCPMC12945276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.